According to the World Health Organization, about 422 million people worldwide have diabetes, and 1.5 million deaths are directly attributed to it each year. To better understand the nuances and factors contributing to the disease and its complications, IHH Malaysia became the first Platinum Sponsor of the Seremban Diabetes (SeDia) Cohort Study in Malaysia, with a contribution of RM 2 million.
Jean-François Naa, CEO of IHH Malaysia, presented a mock cheque at the launch of the longitudinal study by the Ministry of Health and International Medical University on 08 July 2023.
The SeDia Cohort Study will encompass a comprehensive examination of various factors, from genetics and family history of diabetes to lifestyle and environmental factors, dietary regimes, physical activity, socio-economic levels and healthcare delivery. By understanding the complex connections between these factors, the aim is to uncover optimal strategies for diabetes prevention and treatment.
Subsequently, this knowledge can be translated into evidence-based public healthcare policies and programmes that are relevant to the local community. This ensures the efficacy of developed treatment and prevention initiatives in addressing the escalating burden of diabetes in Malaysia.
This 12-year study marks the first important step towards obtaining data that is socio-culturally relevant to the local community. It involves over 5,000 patients registered as part of the Klinik Kesihatan Seremban’s Diabetes Registry and over 7,000 of their family members, to investigate the complex web of interactions that contribute to the development of diabetes and its complications.
Related Stories
.png?sfvrsn=e4a6c77e_1)
Shaping our Future, Sustainably
How do sustainability and healthcare intersect to shape our future? This was the focus of our second HealthcareInsider leadership dialogue this year, themed "Shaping our Future, Sustainably," held on 1 August 2024.
Ukrainian Baby Hears for the First Time After 15 Months
In a heartwarming moment, Leia Dynnyk, a 15-month-old from Ukraine, experienced a miracle when she heard her mother’s voice for the first time after undergoing cochlear implant surgery at Acıbadem Kent Hospital in İzmir, Türkiye.
Transforming Cancer Care with Robotic Precision
Gleneagles HealthCity Chennai recently celebrated a significant milestone in clinical excellence, completing over 100 robotic-assisted cancer surgeries within a year.
Meet Our New Chairman
On 26 June, IHH welcomed veteran business leader and lawyer Tan Sri Dr Nik Norzrul Thani bin N Hassan Thani as Chairman and Independent Non-Executive Director of IHH Healthcare.
Union of Labs
On 1 July, nearly 300 laboratory staff from across the globe - both in-person and online -gathered for our inaugural IHH Labs Town Hall.
IHH Inaugural Risk and Compliance Forum 2024
IHH held its inaugural risk and compliance forum on 2 and 3 July 2024, under the theme of "Navigating Uncertainties. Forming Resilience. Seizing Opportunities”.